Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Richard Blumberg
Brigham and Women's Hospital, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Syntalogic
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Please see attached document for details about the SFI.
TIM family of genes: Role in T cell immunity and tolerance
TIM-3 has emerged as key molecule that induces T cell dysfunction/exhaustion in effector T cells in chronic human viral infections like HIV and HCV and in cancer. In contrast, there is a defect in TIM-3-mediated regulation in the autoimmune disease multiple sclerosis (MS). This proposal will provide a greater understanding of how TIM-3 is induced and how it functions in effector T cells so that the pathway can be therapeutically exploited in chronic microbial infections, cancer, and autoimmune diseases.
Filed on October 29, 2015.
Tell us what you know about Richard Blumberg's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Richard Blumberg”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Richard Blumberg | Brigham and Women's Hospital | Conflict of Interest | Syntalogic | Value cannot be readily determined |
| Richard Blumberg | Brigham and Women's Hospital | Conflict of Interest | Syntimmune, Inc. | $60,000 - $79,999 |
| Richard Blumberg | Brigham and Women's Hospital | Conflict of Interest | Syntimmune, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.